Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Patent
1994-08-22
2000-10-03
Marx, Irene
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
424520, 435371, 435366, 435325, A61B 5055
Patent
active
061269352
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
The invention relates to new cultures of keratinocytes.
The invention also relates to a process for preparing the same.
The invention also relates to the use of new cultures of keratinocytes as wound healing substances.
The invention also relates to pharmaceutical compositions containing as active substances, said new cultures of keratinocytes.
The invention also relates to cosmetic compositions, containing as active substances, new cultures of keratinocytes.
Skin is presumably the organ most subject to injury. Skin repair is a complex process that can be divided in 4 phases usually described as inflammation, granulation tissue formation, epithelialization and remodeling of the connective tissue matrix. Each of these phases is complex in itself, and it is clear that for good wound healing, the processes must occur successively and in coordination. Good wound healing can be defined as restoration of the skin, including the dermal and epidermal part, in such a way that the resulting scar tissue maximally resembles the unwounded skin structurally, histologically, functionally, and esthetically. Obviously, such scar tissue is different from a hypertrophic scar or keloid.
For purposes of clarity a simplified description of the composition of human skin is given below. The upper part is composed of the epidermis, which contains mostly keratinocyte or epithelial cells, some melanocytes and Langerhans cells, and several Merkel cells. Five different layers are found in the epidermis, reflecting the state of keratinization. The proliferating keratinocytes at the base of the epidermis, i.e., in the stratum basal, are attached to the dermis via the basement membrane. The dermis is composed of connective tissue, including fibroblasts and other connective tissue cells, and connective tissue matrix substances. Blood vessels, nerves, sensory organs, sweat glands, sebaceous glands, and hair follicles are present in the dermis.
Clinical and animal experiments have demonstrated that application of in vitro cultured (human) keratinocytes, for instance as sheets, induces wound healing in chronic wounds such as ulcers and in burns, which may be treated concomitantly with meshed split skin autografts. Moreover, there are indications that the application of cultured keratinocyte grafts suppresses hypertrophic scar formation and keloid formation. Initially, autografts were used, which were prepared by growing keratinocytes isolated from the patients own skin. Confluent (differentiated) keratinocyte cultures are then detached from the culture dish and applied as a sheet, with basal cells facing downwards on the wound. About 3 weeks are needed before a reasonable amount of keratinocytes can be cultured for application as an autograft. Even then, the amount may not be sufficient to cover the entire wound surface. However, this time period may be critical for the patient, especially in the case of extensive third degree burns.
Therefore, experiments were undertaken to apply keratinocyte allografts. Keratinocytes are isolated from the skin of one person, cultured to obtain confluent keratinocyte sheets, and then applied on the wound of a patient. No differences in wound healing activity were observed between auto- and allografts. A main disadvantage of cultured allografts is the risk of transferring pathogens such as human immunodeficiency virus, hepatitis B virus, and cytomegalovirus, from the skin donor to the acceptor patient.
These techniques for wound treatment make use of fresh keratinocyte grafts, containing proliferating keratinocytes. The keratinocyte sheets are detached from the culture vessel by treatment with Dispase and immediately applied onto the wound. The availability of these sheets in terms of time and quantity is a major drawback of fresh keratinocyte grafts. It is assumed that proliferating keratinocyte cultures contain higher wound healing activity than more differentiated cultures. Moreover, only a multilayer culture can be detached as a sheet from the culture vessel, and can be sprea
REFERENCES:
patent: 4016036 (1977-04-01), Green et al.
patent: 4254226 (1981-03-01), Eisinger et al.
patent: 4299819 (1981-11-01), Eisinger
patent: 4304866 (1981-12-01), Green et al.
patent: 4443546 (1984-04-01), Stemerman et al.
patent: 4673649 (1987-06-01), Boyce et al.
patent: 4888291 (1989-12-01), Barrandon et al.
patent: 4940666 (1990-07-01), Boyce et al.
patent: 4996154 (1991-02-01), Gabriels, Jr.
patent: 5000983 (1991-03-01), Hefton
patent: 5130142 (1992-07-01), Wong et al.
patent: 5262298 (1993-11-01), Shipley
patent: 5273877 (1993-12-01), Fey et al.
patent: 5273900 (1993-12-01), Boyce
patent: 5460939 (1995-10-01), Hansbrough et al.
Ausubel, F.M. et al. (ed.), Short Protocols in Molecular Biology, 2.sup.nd ed., 1992, pp. 4-11-4-12.
Zyskind, J.W. et al., Recombinant DNA Laboratory Manual, 1989, pp. 12-17.
Silver et al., Int J Tissue React 10 (6). 1988.
Kalish, R.S., The Journal of Immunology, vol. 142(1), pp. 74-80, Jan. 1989.
Schmidt, R. et al., The Journal of Investigative Dermatology, vol. 85(1), pp. 50-53, Jul. 1985.
Malejczyk, J. et al., Int. J. Cancer, vol. 43(2), pp. 209-214, Feb. 1989.
M. Eisinger et al., "Growth regulation of skin cells by epidermal cell-derived factors: Implications for wound healing," vol. 85, pp. 1937-1941, Mar. 1988, Proc. Natl. Acad. Sci., USA.
In Vitro, vol. 16, No. 6, Jun. 1980, pp. 516-525, "Growth and Differentiation of Human Keratinocytes . . . ", D.M. Peehl et al.
Mayo Clinic Proceedings, vol. 61, No. 10, Oct. 1986, Rochester, MN pp. 771-777, Pittelkow et al, "New Techniques for the In Vitro . . . ".
Journal of Cell Biology, vol. 79, No. 2, Nov. 1978, pp. 356-370, Marcelo et al, Stratification, Specialization, and Proliferation . . .
Peehl et al, "Clonal Growth of Human Keratinocytes . . . "In Vitro (USA), vol. 16, #6, 1980, pp. 526-538, abs.
Marx Irene
N.V. Innogenetics S.A.
LandOfFree
Pellets obtained from cell cultures of keratinocytes and their u does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pellets obtained from cell cultures of keratinocytes and their u, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pellets obtained from cell cultures of keratinocytes and their u will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-192320